The "Global Medical Microbiology Testing Technologies Market (2022-2027) by Product, Method, Applications, End-user, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Nov 16, 2022--
The Global Medical Microbiology Testing Technologies Market is estimated to be USD 9.24 Bn in 2022 and is expected to reach USD 15.58 Bn by 2027, growing at a CAGR of 11.02%
Increasing Incidence of Infectious Diseases and Cancer
Increased Funding for R&D and Technological Advancements in Rapid Microbiology Testing
The Stringent Regulations Related to Rapid Microbiology Testing Kits
Technological Advancements in the Rapid Microbiology Testing Kits
Increase in the Number of Research Activities for Microbiology Testing
High Capital Investments and Low Cost-benefit Ratio
The Global Medical Microbiology Testing Technologies Market is segmented based on Product, Method, Applications, End-user, and Geography.
By Product, the market is classified into Consumables, Instruments, and Reagents and Kits.
By Method, the market is classified into Cellular Component-based Rapid Microbiology Testing, Growth-based Rapid Microbiology Testing, Nucleic Acid-based Rapid Microbiology Testing, ad Viability-based Rapid Microbiology Testing.
By Applications, the market is classified into Clinical Disease Diagnostics, Cosmetics & Personal Care Products Testing, Environmental Testing, Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, and Research Applications.
By End-user, the market is classified into Academic Institutes, Contract Research Organizations, Cosmetics & Personal Care Testing Industry, Diagnostic Laboratories & Hospitals, Environmental Study Agencies, Food & Beverage Companies, Pharmaceutical & Biotechnology Companies, and Research Laboratories.
By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
The report presents a detailed Ansoff matrix analysis for the Global Medical Microbiology Testing Technologies Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The analyst analyses the Global Medical Microbiology Testing Technologies Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
6 Global Medical Microbiology Testing Technologies Market, By Product
7 Global Medical Microbiology Testing Technologies Market, By Method
8 Global Medical Microbiology Testing Technologies Market, By Applications
9 Global Medical Microbiology Testing Technologies Market, By End-user
10 Americas' Medical Microbiology Testing Technologies Market
11 Europe's Medical Microbiology Testing Technologies Market
12 Middle East and Africa's Medical Microbiology Testing Technologies Market
13 APAC's Medical Microbiology Testing Technologies Market
Abbott Laboratories, Inc.
Bactest Ltd.
Becton, Dickinson and Company
Biomerieux SA
Biosensia
Bruker Corp.
Charles River Laboratories International, Inc.
Colifast
Cordx
Danaher Corp.
Don Whitley Scientific, Ltd.
Euroclone S.p.A
Gradientech
Lubioscience Gmbh
Merck Kgaa
Neogen Corp.
Quidel Corp.
r-biopharm Ag
Rapid Micro Biosystems, Inc.
Rqmicro Ag
Sartorius Ag
Serosep Ltd.
Solus Scientific Solutions, Ltd.
Thermo Fisher Scientific, Inc.
Vivione Biosciences, LLC
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH TECHNOLOGY OTHER HEALTH SOFTWARE PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/16/2022 07:26 AM/DISC: 11/16/2022 07:26 AM
http://www.businesswire.com/news/home/20221116005588/en